MX2013004069A - Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico. - Google Patents

Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico.

Info

Publication number
MX2013004069A
MX2013004069A MX2013004069A MX2013004069A MX2013004069A MX 2013004069 A MX2013004069 A MX 2013004069A MX 2013004069 A MX2013004069 A MX 2013004069A MX 2013004069 A MX2013004069 A MX 2013004069A MX 2013004069 A MX2013004069 A MX 2013004069A
Authority
MX
Mexico
Prior art keywords
mycoplasma
heamofelis
diagnostic immunoassay
immunoreactive antigens
seq
Prior art date
Application number
MX2013004069A
Other languages
English (en)
Inventor
Joanne Belle Messick
Andrea Pires Santos
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of MX2013004069A publication Critical patent/MX2013004069A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof

Abstract

Se proporcionan composiciones para uso en selecciones de diagnóstico para Mycoplasma haemofelis. En una modalidad un péptido inmunogénico seleccionado de SEQ ID NO: 1 hasta SEQ ID NO: 60, o un fragmento del mismo, se inmoviliza en un soporte sólido y se usa para detectar la presencia de anticuerpos Mycoplasma haemofelis en un fluido corporal del paciente. De acuerdo con una modalidad se proporciona un método para detectar una infección por Mycoplasma haemofelis en una especie felina.
MX2013004069A 2010-10-15 2011-10-13 Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico. MX2013004069A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39367010P 2010-10-15 2010-10-15
US40829610P 2010-10-29 2010-10-29
US40890210P 2010-11-01 2010-11-01
PCT/US2011/056066 WO2012051372A2 (en) 2010-10-15 2011-10-13 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay

Publications (1)

Publication Number Publication Date
MX2013004069A true MX2013004069A (es) 2013-05-17

Family

ID=45938963

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004069A MX2013004069A (es) 2010-10-15 2011-10-13 Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico.

Country Status (5)

Country Link
US (1) US9804159B2 (es)
EP (1) EP2628009A4 (es)
CA (1) CA2814673A1 (es)
MX (1) MX2013004069A (es)
WO (1) WO2012051372A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
WO2014014897A2 (en) * 2012-07-16 2014-01-23 The Scripps Research Institute Immunoglobulin-binding human mycoplasma antigens and methods of use thereof
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336603A (en) 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US5183740A (en) 1990-02-23 1993-02-02 The United States Of America As Represented By The Secretary Of The Navy Flow immunosensor method and apparatus
WO1993023434A2 (en) 1992-05-19 1993-11-25 Xoma Corporation Bpi-immunoglobulin fusion proteins
FI92882C (fi) 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US6277375B1 (en) 1997-03-03 2001-08-21 Board Of Regents, The University Of Texas System Immunoglobulin-like domains with increased half-lives
US6319691B1 (en) 1999-06-15 2001-11-20 Usa Universe Bioengineering, Inc. Fusion proteins comprising IFN-alpha2b and TM-alpha1
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US7833534B2 (en) * 2006-04-10 2010-11-16 Infectious Disease Research Institute Compounds and methods for diagnosis and treatment of leishmaniasis

Also Published As

Publication number Publication date
WO2012051372A2 (en) 2012-04-19
EP2628009A2 (en) 2013-08-21
US20130210671A1 (en) 2013-08-15
WO2012051372A3 (en) 2012-07-26
CA2814673A1 (en) 2012-04-19
EP2628009A4 (en) 2014-04-02
US9804159B2 (en) 2017-10-31

Similar Documents

Publication Publication Date Title
NZ601022A (en) Diagnosis and treatment of cancer using anti-ereg antibody
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
WO2011015602A3 (en) Lung cancer biomarkers
DK2396652T3 (da) Diagnose af inflammatorisk tarmsyndrom baseret på cytoletalt udspilende toksin
NZ707116A (en) Ly75 as cancer therapeutic and diagnostic target
MX2013004069A (es) Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico.
EP2720043A3 (en) HMGB1 and anti-HMGB1 antibodies for the prognosis of neurological disorders
FR2896588B1 (fr) Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
BR112012018841A2 (pt) "estrutura para a redução de uma resistência ao fluxo de um corpo em um fluido"
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
WO2011093675A3 (ko) 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커
WO2007005627A8 (en) Tuberculosis antigen detection assays and vaccines
WO2009005040A1 (ja) 緑膿菌の外膜タンパク質pa4710
DE102005011421A8 (de) Bestimmung von kurzkettiger SRL-Alkoholdehydrogenase (DHRS4) als Biomarker für Entzündungen und Infektionen
WO2011112670A3 (en) Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
WO2008136510A1 (ja) 自己免疫性膵炎及び劇症１型糖尿病の検査方法及び検査試薬
NZ595026A (en) Immunological method for detecting active jcv infection
FR2968767B1 (fr) Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2012140148A3 (en) Junction plakoglobin for diagnosis of cardiovascular diseases
EP3153861A3 (en) Biomarkers for predicting response to a cancer vaccine
GB0706558D0 (en) Diagnostic assay
WO2010128232A3 (fr) Méthode de diagnostic des infections à propionibacterium acnes
BR112014022145A2 (pt) peptídeos de interferência e método para detecção de micro-organismos
WO2007142695A3 (en) Methods and materials for the detection of leishmania infection
PL401502A1 (pl) Epitop i jego zastosowanie

Legal Events

Date Code Title Description
FA Abandonment or withdrawal